SUMMARY Cardiac output, plasma volume and regional hemodynamic factors involved in blood pressure regulation were investigated in hypertensive patients refractory to the combined treatment with diuretics, propranolol and hydralazine. The patients were compared to hypertensive patients, matched for sex, age, weight, glomerular filtration rate and initial untreated blood pressure, responding adequately to the corresponding therapy. Cardiac output was determined with the dye-dilution technique (indocyanine green) and plasma volume with Evans Blue. Blood flow and vascular resistance at rest and at maximal vasodilatation in a skin (hand) and a muscle (calf) vascular bed were determined using venous occlusion plethysmography and intra-arterial and auscultatory blood pressure recordings, respectively. Maximal vasodilatation was obtained by direct and indirect heating, arterial occlusion and hand muscle work (hand), or by arterial occlusion and muscle work (calf).
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The refractory patients had increased total peripheral resistance in comparison with the responders, while cardiac output and plasma volume did not differ between the groups. This suggests that increased peripheral resistance is the important factor for sustained blood pressure elevation during the influence of the actual therapy. Furthermore, compared with the controls, the refractory patients had increased vascular resistance at maximal dilatation. This indicates a vascular abnormality in this group. Since the dilatation procedure abolishes smooth muscle tone in the resistance vessels almost completely, the vascular abnormality is interpreted as a structural change most likely, an adaptive thickening of the vessel wall associated with hypertension. The results indicate that this abnormality is more pronounced in the patients refractory to treatment. SOMETIMES, PATIENTS DO NOT RESPOND satisfactorily to antihypertensive treatment. In our homogeneously investigated and treated series of unselected hypertensive men the frequency of patients responding inadequately to therapy was 29% during the first year.' All these patients, however, should not be designated as "refractory" or "non-responders," since the reason for inadequate response was usually poor compliance or administration of doses of the antihypertensive drugs which were too low. 2 The term "frefractory" should be limited to patients who, in spite of adequate treatment and good compliance, still do not respond, or respond inadequately. The prevalence of refractory hypertension in this sense was 3% in the same study.2 The reasons for poor response to therapy in these cases might be found in pharmacological characteristics of the therapy, such as inadequate absorption or rapid inactivation of the absorbed drugs, although such reasons probably are rare. A more likely explanation is that the hypertensive disease and/or the sensitivity to the actual therapy is different in the non-responder group, and that ineffective reduction of cardiac output -direct or via failure to reduce plasma volume -and/or the peripheral vascular resistance would result in refractory hypertension.
The aim of the present study was to investigate some hemodynamic parameters in a series of nonresponding hypertensives compared with matched responders to explain the poor response to therapy.
Materials
Ten patients, all middle-aged men (50-60 years) with primary hypertension refractory to treatment 615 After placement of the catheters, when the patients had been resting in a supine position for at least 30 minutes, Evans Blue was injected for the plasma volume determination. Blood samples were drawn from the central circulation 5, 10, 15 and 20 minutes after the injection. The hypothetical plasma concentration of the dye at zero time was estimated from a plot of log concentration against time. From that concentration and the originally injected amount of dye, plasma volume was calculated.5
The intra-arterial blood pressure was recorded with a pressure transducer (EMT 34, Siemens-Elema). This pressure and the electrocardiogram, from which heart rate was calculated, were recorded on a Mingograph 81 (Siemens-Elema). MAP was obtained from electrically damped curves and measured immediately before each cardiac output (CO) determination. Auscultatory pressure was recorded at Korotkoff phase 5 (disappearance). Mean auscultatory arterial pressure (MAPA) was calculated as the diastolic blood pressure + 1/3 of the pulse pressure. Simultaneous direct and indirect brachial artery pressures were determined, but only once. Although direct and indirect blood pressures correlated well (r = 0.88), there was a systematic difference between them, with intraarterial pressures lower. Since the same method was used in the two groups, the comparison of nonresponders and responders was not disturbed by this systematic difference.
CO was determined by the indicator dilution technique using a densitometer (Cardiognost, Atlas) and indocyanine green (Cardio-Green). A continuous dye concentration curve was registered in blood from the brachial artery, drawn at constant speed by a motordriven syringe. The blood was heparinized and reinfused after each determination, and the mean from five separate determinations at 5-minute intervals was used. Stroke volume (SV) was calculated by dividing CO by heart rate (HR). Total peripheral resistance (TPR) was obtained by dividing mean intra-arterial blood pressure in the brachial artery (MAP) by CO. It was expressed in arbitrary units (U). CO, TPR and SV were corrected for body surface area (BSA), and CI, TPRI and SV indices were derived.
Hand blood flow determinations were started 2 hours after the end of the central hemodynamic investigation. In the pause, the patients had coffee and a sandwich but were not allowed to smoke. One hour before flow determinations and during the whole experiment, the patients were exposed to heating until intense perspiration occurred in order to abolish the sympathetic vasoconstrictor activity to the skin vessels of the hand.6' 7 Hand blood flow (sympathoplegic flow) was then determined by venous occlusion plethysmography and the blood pressure was recorded intraarterially in the contralateral brachial artery. The water temperature in the plethysmograph was kept at 330 C, and five recordings of blood flow with simultaneous readings of MAPs were taken. The flow resistance during these circumstances was designated sympathoplegic resistance (R.ymp). The plethysmograph temperature was then increased to 430 C. After 3-4 minutes of arterial occlusion at this temperature, while the patients exercised their hand muscles to the point of ischemic pain, another four or five flow readings were taken. From the highest flow value and the corresponding MAP, resistance at maximal dilatation or minimal resistance (Rmin) was calculated and as a rule, the mean of three separate determinations of this resistance was used. The ratio between blood flow resistance at rest and that during maximal vasodilatation will be referred to as sympathoplegic tone, as it is felt to reflect the extent of smooth muscle contraction of the resistance vessels in the hand remaining after vasoconstrictor blockade.6 7 Blood flow resistance is expressed in PRU1,O, i.e., mean blood pressure (mm Hg) divided by blood flow (ml/100 ml * min).
On the following morning each patient returned to the laboratory. The arterial circulation was then examined in the calves, first by oscillometry in an attempt to exclude arteriosclerotic or other large vessel abnormalities.8 The calf muscle flow was then recorded with venous occlusion plethysmography using the strain gauge technique.9 The blood pressure was measured indirectly in the brachial artery simultaneously with the flow determination. Initially, five readings were taken with the patient resting, and the resistance at rest (Rrest) was calculated. Then arterial occlusion was applied for 3-4 minutes and the patients exercised the calf muscle by pedalling on a special foot ergometer until ischemic pain occurred. The pedalling time was measured. After the arterial occlusion was released, five readings of blood flow were made. The highest flow value and the corresponding mean blood pressure were used to calculate Rmin. As a rule the mean of three separate determinations was used. The ratio between Rrest and the Rmin will be referred to as vascular resting tone, considered to reflect the extent of smooth muscle contractation of the resistance vessels in the calf at rest.
Standard methods were used for calculation of the mean, SD and r value. The hypothesis of no difference in means was tested by t test for independent data.
Only two-tailed tests were used and differences were considered significant for P values <0.05.
Results

Plasma Volume
The hematocrits did not differ between refractory patients and responders, so differences in total blood volume are reflected by the plasma volumes (table 3) . Ideally, a prospective study should be used for studying problems such as poor response to antihypertensive therapy. However, this would need considerably more patients than in the present series, as there is no way of predicting which patient will or will not respond to a given treatment. This is well-known from studies in which only one drug has been given,10' 11 and the problem of predicting the response in patients requiring multiple drug treatment presumably is no less. For this reason we were restricted to a retrospective study in which the refractory patients were compared to matched responders. The refractory and the responding patients were then investigated in order to find hemodynamic differences related to the difference in therapeutic response.
It has been shown with several antihypertensive drugs that resistance to treatment in hypertension is associated with sodium retention and expanded extracellular fluid volume.'2 13 In the present patient series there was no significant difference between the refrac- tory and the responding group in total plasma volume, nor was there any significant difference between the groups when plasma volume was expressed in ml/cm body height, a more reliable and reproducible indicator of intravascular volume."4 15 A trend toward higher values in the refractory group could be seen, however, and the lack of significance may possibly be due to the small number of patients. On the other hand, since CO was the same in the two groups and since the increased volume is thought to act on blood pressure via an elevated CO, a volume factor explaining the high pressure in the refractory group seems unlikely. Regarding other possible differences, all patients had a high and identical degree of fl-adrenoceptor blockade as shown by isoproterenol stimulation.2
Furthermore, no difference between refractory patients and responders was shown in regard to CO, HR or SV (table 4) . Consequently, with a substantially higher MAP the refractory patients had a significantly increased total peripheral resistance. An increased resistance could either be due to increased smooth muscle tone-22 in the resistance vessels and/or to structural changes in these vessels.23 26 Increased vascular smooth muscle tone in a group of patients can have several explanations, e.g., a higher vasomotor nerve tone, increased amounts of circulating pressor substances, increased sensitivity to vasoconstrictor substances, electrolyte differences and/or differences in myogenic tone. In this material the possibility also exists that the antihypertensive drugs affected vascular smooth muscle tone differently. Concerning the vasodilator used, the dose of hydralazine was the same in the two groups. Consequently, as all patients refractory to treatment were shown to be slow acetylators, they should have equal or higher plasma concentrations of the drug than their matched controls, since four patients in that group were fast acetylators. Furthermore, the peripheral hemodynamic studies indicated that vascular tone in the resting calf muscle was the same in the two groups (vascular tone at rest, table 5) as was the vascular tone in the hand (skin) at rest, during functional vasomotor blockade (sympathoplegic tone, table 6). The higher pressure in the refractory group, therefore, cannot be explained by an increased vascular smooth muscle tone in that group.
Another possible explanation for an increased vascular resistance in hypertension is structural changes in the resistance vessels. It has been shown that such structural changes are of great hemodynamic importance in established hypertension in man and animal.23 28 To study the possible role of this factor as an explanation for the higher pressure in the refractory group compared to the responders, blood flow resistance in the hand and in the calf at maximal dilatation was also determined. The procedure for dilatation of the blood vessels in the hand is known to give an almost complete relaxation of the smooth muscles in these resistance vessels.24 25 With the procedure for maximal dilatation of the calf blood vessels, it has been shown that big doses of isoproterenol (3 ,ug/min) given in the femoral artery cannot add to the dilatation induced by ischemic work (Hansson E., Sivertsson R.: personal communication).
However, the vasoconstriction induced by large doses of norepinephrine given in the femoral artery (3 Ag/min) is not completely overridden by the vasodilatation induced by ischemic work, but the effect of norepinephrine on the resistance is rather small. Thus, it was observed that this norepinephrine dose which increased resting resistance in the calf 140-150% increased the Rmin less than 30% (Hansson E., Sivertsson R.: personal communication).
It can be concluded that the method used for dilatation of the calf blood vessels seems to induce a very intense relaxation of the smooth muscle cells in the resistance vessels. The higher resistance in the hand and the calf at maximal dilatation in the refractory group therefore strongly suggests the existence of more severe structural vascular changes in the refractory group than in the responding group. It is most likely that the structural changes in these patients are primarily due to a relative wall thickening in the resistance vessels, i.e., increased wall/lumen ratio.23'25,26, 29, 30 Theoretically, the higher Rmin in the refractory group could be due to more severe arteriosclerotic changes of the big arteries of those patients, but the findings of a normal oscillometry in the legs and no difference in blood pressure in the left and right arms of responders and non-responders, respectively, do not suggest arteriosclerotic changes in the brachial or femoral arteries in any of the two patient groups.
The more extensive structural vascular changes in the refractory patients compared to the responders could be explained by more pronounced changes in the non-responders before treatment. Alternatively, the explanation could be that the vascular changes, though initially of the same severity, were more reversible on blood pressure lowering therapy in the responding group than in the refractory group.31
Since CO was equal in hypertensive refractory patients and patients responding to a combined treatment with diuretics, propranolol and hydralazine, it can be concluded that the higher blood pressure in the refractory group is due to a higher total peripheral resistance in these patients. As-judged from the hemodynamic picture in the periphery the higher resistance in the refractory group is due to more pronounced structural vascular changes, indicating a more severe hypertensive vascular disease in this group than in the responders. Smooth muscle tone in the resistance vessels seems to be the same in the two groups. More pronounced structural changes, in turn, may be the result of longer duration of the hypertensive disease or increased disposition to develop arteriolar hypertrophy. 18 SUMMARY The occurrence of the C3F allele was investigated in the following three groups: 69 consecutive referred patients with untreated essential hypertension, including borderline hypertension; 70 patients with established and treated essential hypertension, already attending the same outpatient clinic, and 62 age-and sexmatched normotensive healthy subjects without clinical signs of atherosclerosis or familial predisposition to hypertension. In the three groups the C3F allele was found in 38.2%, 29% and 20%, respectively. Among the treated hypertensive patients with the C3F gene, 40% had coronary heart disease (CHD) compared to 6.1% among the C3F negative (P < 0.005), and the relative risk of CHD among the treated hypertensive patients with this allele was found to be 10.2 (P < 0.002). The C3F gene was present in 72.7% of the treated patients with CHD. In the untreated patients the occurrence of CHD was low, and no differences between C3F positive and negative patients could be demonstrated. No association of the C3F allele with familial predisposition to hypertension was found. This study provides further evidence of a positive association of the C3F allele with atherosclerosis, and it is concluded that this allele in a hypertensive patient might accelerate the atherosclerotic process, with subsequent premature development of vascular complications.
GENETIC FACTORS predispose to hypertension and coronary heart disease (CHD)." 2 It has been suggested that some of these factors might act via immunological pathways,3 8 including the complement system.9' 10 By using high voltage electrophoresis the
